Deinove has chosen Processium to develop carotenoid separation/purification techniques at an industrial scale and to transpose the production process from the laboratory to industry.
Deinove discovers, develops and produces high-value compounds from rare bacteria, notably from the Deinococcus genus.
It plans to market the carotenoids produced directly to the healthcare, nutrition and cosmetics industrials.
This business is expected to start generating revenue in 2018.
In 2016, Deinove obtained proof of concept for the production of carotenoid molecules from optimized Deinococcus strains:
1. Five conventional molecules with known applications and identified markets;
2. One new molecule, Deinoxanthin, which must undergo characterization tests and a regulatory clearance before it can be marketed.
The company aims to market carotenoids in the form of ingredients directly to the industrials of its target markets.
It does not have plans to develop its own manufacturing facilities, but will subcontract production, including the large-scale fermentation, extraction, purification and formulation stages.
With Deinove, Processium will be developing and validating an industrial process for extracting carotenoids from the fermentation medium to obtain a marketable product.
It will also identify and select subcontractors that can start production quickly.
